idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
idw - Informationsdienst
Wissenschaft
In a nutshell:
• New developmental disorder discovered: Variants of the UNC13A gene cause severe neurological impairments.
• Three forms of developmental disorder identified: Depending on the gene variant, affected individuals exhibit different symptoms of diverse severity and have different underlying molecular mechanisms.
• Possible approach for therapies: In the future, antisense oligonucleotide therapies that exclusively suppress the production of disease-causing UNC13A protein copies could alleviate the symptoms in two forms of the disease.
Whether we are writing an email, rushing for a bus, or humming a tune, every thought, feeling, and action relies on communication between our roughly 100 billion nerve cells. This exchange of information happens at synapses, where messenger substances are passed from one cell to another. One key player in this process is the protein UNC13A (Munc13-1), which enables the release of neurotransmitters – the messenger substances of the brain. Beyond that, UNC13A is also essential for the adaptability of synapses, a property crucial for learning and memory.
New developmental disorder
Variations in the UNC13A gene, which contains the blueprint for the UNC13A protein, can trigger a previously unknown neurological developmental disorder. This was discovered by research led by Nils Brose at the Max Planck Institute for Multidisciplinary Sciences (Göttingen, Germany) and Noa Lipstein, formerly a member of Brose’s department and now group leader at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (Berlin, Germany), together with clinical geneticists Anita Rauch (University of Zurich, Switzerland) and Reza Asadollahi (University of Greenwich, UK). Their findings were recently published in the journal Nature Genetics.
In collaboration with multiple clinics worldwide, they have so far identified 50 patients diagnosed with this syndrome – and many of them have now received an explanation for its cause. The spectrum of impairments caused by the gene alterations ranges from delayed development and intellectual disabilities to impaired speech and motor function, tremors, and epileptic seizures. In some cases, it can even lead to death in early childhood.
Three forms of developmental disorder
Brose’s Department of Molecular Neurobiology has studied the function of the UNC13A protein for many years. This long-term effort allowed the team to decipher the causes of the developmental disorder at the molecular level. Using electrophysiological studies on mice and the nematode C. elegans, the research team investigated how different genetic variations of the UNC13A gene affect the function of nerve cell synapses. So far, the researchers have identified the mechanisms by which genetic variants in 20 patients cause disease.
“The symptoms vary depending on which function of the UNC13A protein is affected,” explains Lipstein. “The disorder can be grouped into three subtypes, each of which is caused by different impairments in nerve cells communication. Each subtype causes its own set of symptoms and therefore requires its own therapeutic approach, even though the cause lies in the same gene,” she emphasizes.
Approaches for new therapies
The researchers’ findings offer hope for new therapies: “For example, antisense oligonucleotide therapies, which suppress the production of disease-causing proteins and thus increase the relative abundance of normal UNC13A protein, could potentially reduce the symptoms of two forms of this developmental disorder,” Brose says. The new findings may also aid in the development of treatments for neurodegenerative diseases, such as ALS, frontotemporal dementia, and Alzheimer’s disease. Recent studies have shown that altered UNC13A protein production is a key factor in the progression of these diseases.
“Our studies highlight the importance of long-term basic research. Identifying the precise molecular basis of this developmental disorder is a crucial step toward developing future treatment methods,” Lipstein notes.
Prof. Dr. Nils Brose
Department of Molecular Neurobiology
Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany
Phone: +49 551 201-31725
Email: brose@mpinat.mpg.de
Asadollahi, R. et al.: Pathogenic UNC13A variants cause a neurodevelopmental syndrome by impairing synaptic function. Nature Genetics (October 22, 2025)
https://doi.org/10.1038/s41588-025-02361-5
https://www.mpinat.mpg.de/5138283/pr_2522 – Original press release
https://www.mpinat.mpg.de/brose – Department of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences
Nerve cells (green) form neural networks in which information is transmitted. Errors in this communi ...
Quelle: Pia Venneker
Copyright: Leibniz-FMP
Merkmale dieser Pressemitteilung:
Journalisten, Wissenschaftler, jedermann
Biologie, Medizin
überregional
Forschungsergebnisse, Wissenschaftliche Publikationen
Englisch
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
